“Dyadic International (NASDAQ: DYAI) Revolutionizing Pharma with Innovative C1 Technology for Global Protein Development”
The biotechnology firm, specializing in the creation of microbial and fungal-based gene expression technology platforms, appears poised to potentially transform the pharmaceutical sector with its exceptionally innovative solutions. A key…